Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
2024-02-14 4:05 pm Purchase | 13G | SAB BIOTHERAPEUTICS INC NE SABS | COMMODORE CAPITAL LP | 1,831,746 3.5% | 1,831,746 (New Position) | View |
2024-02-14 07:02 am Purchase | 13G | SAB BIOTHERAPEUTICS INC NE SABS | RTW INVESTMENTS LP | 9,220,672 9.99% | 9,220,672 (New Position) | View |
2024-02-14 06:28 am Sale | 13G | SAB BIOTHERAPEUTICS INC SABS | Radcliffe Capital Management L.P. | 0 0% | -627,555 (Position Closed) | View |
2023-12-04 4:33 pm Purchase | 13G | SAB BIOTHERAPEUTICS INC SABS | BIOTECHNOLOGY VALUE FUND L P | 9,178,282 9.99% | 9,178,282 (New Position) | View |
2023-10-16 4:05 pm Purchase | 13G | SAB BIOTHERAPEUTICS INC SABS | COMMODORE CAPITAL LP | 6,932,463 9.9% | 6,932,463 (New Position) | View |
2022-12-16 4:33 pm Purchase | 13D | SAB BIOTHERAPEUTICS INC SABS | HAMILTON CHRISTINE E | 8,712,045 17.3% | 98,803 (+1.15%) | View |
2022-09-08 5:07 pm Purchase | 13D | SAB BIOTHERAPEUTICS INC SABS | Sullivan Eddie Joe | 5,719,113 13.3% | 14,000 (+0.25%) | View |
2022-09-08 5:04 pm Sale | 13D | SAB BIOTHERAPEUTICS INC SABS | HAMILTON CHRISTINE E | 8,613,242 20% | -2,072,736 (-19.40%) | View |
2022-05-27 4:24 pm Sale | 13D | SAB BIOTHERAPEUTICS INC SABS | Big Cypress Holdings LLC | 965,299 2.2% | -2,084,026 (-68.34%) | View |
2022-02-14 06:09 am Purchase | 13G | SAB BIOTHERAPEUTICS INC SABS | Radcliffe Capital Management L.P. | 627,555 1.44% | 627,555 (New Position) | View |
2022-02-11 3:39 pm Unchanged | 13G | SAB BIOTHERAPEUTICS INC SABS | BASSO CAPITAL MANAGEMENT L.P. | 0 0% | 0 (Unchanged) | View |
2021-11-01 7:38 pm Purchase | 13D | SAB BIOTHERAPEUTICS INC SABS | Big Cypress Holdings LLC | 3,049,325 7% | 3,049,325 (New Position) | View |
2021-11-01 4:57 pm Purchase | 13D | SAB BIOTHERAPEUTICS INC SABS | HAMILTON CHRISTINE E | 10,685,978 24.58% | 10,685,978 (New Position) | View |
2021-11-01 4:55 pm Purchase | 13D | SAB BIOTHERAPEUTICS INC SABS | Sullivan Eddie Joe | 5,705,113 13.12% | 5,705,113 (New Position) | View |
2021-10-19 09:51 am Purchase | 13G | BIG CYPRESS ACQUISITION CORP C BCYP | Radcliffe Capital Management L.P. | 1,296,891 8.77% | 1,296,891 (New Position) | View |
2021-02-24 10:00 am Purchase | 13G | BIG CYPRESS ACQUISITION CORP C BCYP | BASSO CAPITAL MANAGEMENT L.P. | 757,794 5.12% | 757,794 (New Position) | View |